FDA clears updated Covid vaccines for seniors and high-risk adults

The FDA approved updated Covid vaccines from Pfizer‑BioNTech and Moderna for adults 65+ and those with underlying health conditions (with a Sanofi non‑mRNA option also cleared), with rollout expected in the coming days. Federal guidance on who should get the shots remains unsettled due to ongoing legal challenges to the vaccine advisory panel, though vaccines are being prepared for distribution at pharmacies and other sites. Medical societies have guidance in motion, uptake remains a concern, and insurers have pledged continued coverage as access varies by state.